G-7 Countries To Supply Additional 870 M Doses of COVID-19 Vaccines
By

By
Leaders from the G-7 countries (Canada, France, Germany, Italy, Japan, the UK, and the US) announced at the G-7 Summit, held earlier this month (June 2021) in Cornwall, UK, that…

Civica Rx Names New Retail Generics Unit, Catalent as Mfg Partner
By

By
Civica Rx, a non-profit pharmaceutical company providing generic drugs, including drugs in shortage, has announced CivicaScript as the name of its new retail generics operating unit. Additionally, Anthem, a health…

Elanco To Sell Two Mfg Sites to CDMO TriRx Pharmaceuticals
By

By
Elanco Animal Health, the former animal-health business of Eli Lilly and Company and now a stand-alone company, has agreed to sell two manufacturing sites in Shawnee, Kansas, and Speke, UK…

Bayer To Invest $303 M in New Production Plant in Finland
By

By
Bayer is investing EUR 250 million ($303 million) to build a new pharmaceutical plant and concurrently modernize its existing production plant in Turku, Finland. The new production plant will be…

Biden Administration Calls for Action To Improve Pharma Supply Chains
By

By
The Biden Administration has announced a series of actions and recommendations to improve supply-chain resilience in several industries, including pharmaceuticals. In February (February 2021), President Joe Biden issued an executive…

EU Calls for WTO Action To Expand Access for COVID-19 Vaccines
By

By
The European Union (EU) has submitted its proposal seeking the commitment of World Trade Organization (WTO) members for a multilateral trade action plan to expand the production of COVID-19 vaccines…

Merck & Co. in $1.2-Bn Supply Pact with US Gov’t for Oral COVID-19 Drug
By

By
Merck & Co. has entered into a procurement agreement, worth up to $1.2 billion, with the US government for molnupiravir, its investigational oral antiviral agent for treating mild-to-moderate COVID-19. Molnupiravir…

Pharma COVID Roundup: News from Pfizer, Moderna, and Roche
By

By
The latest on COVID-19 vaccines/drugs, manufacturing, and testing from Pfizer, Moderna, Roche, Thermo Fisher, Inovio, Regeneron, the US government, and others. Manufacturing and supply of COVID-19 vaccines and drugs Pfizer/BioNTech,…

Global Pharma Briefs: News from Sanofi, Otsuka, and bluebird bio
By

By
A roundup of news from Canada (Fusion Pharmaceuticals), France (Sanofi), Japan (Otsuka), and the US (bluebird bio). Canada Fusion Pharmaceuticals Partners for New Radiopharma Mfg FacilityFusion Pharmaceuticals, a Hamilton, Ontario,…

Moderna Partners with UNICEF, Lonza, Thermo Fisher for COVID-19 Vaccine
By

By
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has signed a pact with UNICEF to supply up to 500 million doses of its COVID-19 vaccine and has…